KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Times Interest Earned (2016 - 2026)

Biocryst Pharmaceuticals filings provide 15 years of Times Interest Earned readings, the most recent being $18.42 for Q4 2025.

  • On a quarterly basis, Times Interest Earned rose 10090.73% to $18.42 in Q4 2025 year-over-year; TTM through Dec 2025 was $4.32, a 16848.58% increase, with the full-year FY2025 number at $4.32, up 16848.58% from a year prior.
  • Times Interest Earned hit $18.42 in Q4 2025 for Biocryst Pharmaceuticals, up from $1.51 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $18.42 in Q4 2025 to a low of -$3.98 in Q1 2021.
  • Median Times Interest Earned over the past 5 years was -$0.71 (2022), compared with a mean of $0.0.
  • Biggest five-year swings in Times Interest Earned: rose 0.83% in 2023 and later soared 10090.73% in 2025.
  • Biocryst Pharmaceuticals' Times Interest Earned stood at -$2.78 in 2021, then soared by 37.0% to -$1.75 in 2022, then rose by 0.83% to -$1.74 in 2023, then surged by 89.38% to -$0.18 in 2024, then surged by 10090.73% to $18.42 in 2025.
  • The last three reported values for Times Interest Earned were $18.42 (Q4 2025), $1.51 (Q3 2025), and $1.38 (Q2 2025) per Business Quant data.